Rapiblyk 280 mg lyophilized powder for injection Images
Generic Name: landiolol
This medication has been identified as Rapiblyk 280 mg lyophilized powder for injection. It is supplied by AOP Orphan Pharmaceuticals GmbH.
Rapiblyk is used in the treatment of Supraventricular Tachycardia and belongs to the drug classes cardioselective beta blockers, group II antiarrhythmics. Rapiblyk 280 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Rapiblyk
- Generic Name
- landiolol
- Strength
- 280 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers, Group II antiarrhythmics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AOP Orphan Pharmaceuticals GmbH
- National Drug Code (NDC)
- 84381-0110
More about Rapiblyk (landiolol)
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- FDA approval history
- Drug class: cardioselective beta blockers
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.